NYSE:SGFY - Signify Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $26.33
  • Forecasted Upside: 66.14 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$15.85
▲ +0.99 (6.66%)

This chart shows the closing price for SGFY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Signify Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SGFY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SGFY

Analyst Price Target is $26.33
▲ +66.14% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Signify Health in the last 3 months. The average price target is $26.33, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 66.14% upside from the last price of $15.85.

This chart shows the closing price for SGFY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 investment analysts is to buy stock in Signify Health.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/12/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/12/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/11/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/9/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/7/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/7/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/6/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/6/2022Piper SandlerBoost Price TargetOverweight$27.00 ➝ $32.00Medium
5/16/2022Robert W. BairdUpgradeNeutral ➝ Outperform$19.00 ➝ $16.00Low
5/6/2022Deutsche Bank AktiengesellschaftLower Price Target$29.00 ➝ $26.00High
3/29/2022GuggenheimInitiated CoverageBuy$36.00High
3/21/2022The Goldman Sachs GroupBoost Price TargetBuy$20.00 ➝ $22.00High
3/9/2022CowenLower Price TargetMarket Perform$27.00 ➝ $18.00High
3/9/2022UBS GroupUpgradeNeutral ➝ Buy$20.00 ➝ $21.00High
3/6/2022Piper SandlerLower Price TargetOverweight$34.00 ➝ $27.00Medium
2/11/2022The Goldman Sachs GroupInitiated CoverageBuy$20.00Medium
1/25/2022Deutsche Bank AktiengesellschaftLower Price Target$31.00 ➝ $29.00High
11/15/2021Deutsche Bank AktiengesellschaftLower Price TargetBuy$36.00 ➝ $31.00Medium
11/11/2021Piper SandlerLower Price TargetOverweight$42.00 ➝ $34.00High
9/23/2021Robert W. BairdDowngradeOutperform ➝ Neutral$30.00 ➝ $24.00High
9/9/2021CowenInitiated CoverageMarket Perform$27.00High
8/12/2021BarclaysUpgradeEqual Weight ➝ Overweight$30.00Low
7/12/2021JPMorgan Chase & Co.Initiated CoverageOverweight$36.00High
5/27/2021Robert W. BairdInitiated CoverageOutperform$30.00Low
3/26/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$35.00 ➝ $39.00High
3/8/2021BarclaysInitiated CoverageEqual Weight$30.00High
3/8/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$35.00Medium
3/8/2021William BlairInitiated CoverageOutperformMedium
3/8/2021UBS GroupInitiated CoverageNeutral$34.00Medium
3/8/2021Piper SandlerInitiated CoverageOverweight$42.00Medium
3/8/2021The Goldman Sachs GroupInitiated CoverageNeutral$31.00Medium
3/8/2021Bank of AmericaInitiated CoverageBuy$34.00Medium
(Data available from 7/6/2017 forward)

News Sentiment Rating

0.77 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/8/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/7/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/6/2022
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/8/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/7/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/7/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/6/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/6/2022

Current Sentiment

  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Signify Health logo
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $15.85
Low: $14.42
High: $15.88

50 Day Range

MA: $13.32
Low: $11.19
High: $15.85

52 Week Range

Now: $15.85
Low: $10.70
High: $30.89

Volume

1,854,840 shs

Average Volume

1,525,326 shs

Market Capitalization

$3.70 billion

P/E Ratio

83.43

Dividend Yield

N/A

Beta

1.08

Frequently Asked Questions

What sell-side analysts currently cover shares of Signify Health?

The following equities research analysts have issued research reports on Signify Health in the last year: Barclays PLC, Cowen Inc, Deutsche Bank Aktiengesellschaft, Guggenheim, JPMorgan Chase & Co., Piper Sandler, Robert W. Baird, The Goldman Sachs Group, Inc., and UBS Group AG.
View the latest analyst ratings for SGFY.

What is the current price target for Signify Health?

0 Wall Street analysts have set twelve-month price targets for Signify Health in the last year. Their average twelve-month price target is $26.33, suggesting a possible upside of 66.1%.
View the latest price targets for SGFY.

What is the current consensus analyst rating for Signify Health?

Signify Health currently has 1 hold rating and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SGFY will outperform the market and that investors should add to their positions of Signify Health.
View the latest ratings for SGFY.

What other companies compete with Signify Health?

How do I contact Signify Health's investor relations team?

Signify Health's physical mailing address is 800 CONNECTICUT AVENUE, NORWALK CT, 06854. The company's listed phone number is 203-541-4600 and its investor relations email address is investor.relations[email protected] The official website for Signify Health is www.signifyhealth.com. Learn More about contacing Signify Health investor relations.